Join the Prevention Technology Transfer Center (PTTC) Network
Tuesday, March 17, 2020
2:00 pm - 3:30 pm EST
Opioid overdose is a significant public health issue, with people who inject drugs (PWID) a key risk group. However, there is little contemporary information on opioid overdose incidence in Australia and limited evidence of the impact of factors affecting incidence among PWID. Further evidence on the risk and protective factors of an opioid overdose will help determine how to prevent these overdoses from occurring.
Prevention Plus Wellness (PPW) provides easy to use evidence-informed resources to help prevention and health specialists and parents prevent youth and young adult alcohol, cannabis, tobacco, e-cigarette, and opioid use while promoting protective wellness lifestyles.
Abstract | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse.
The IOTOD conference offers a range of exciting and interactive sessions, involving thought-provoking talks and expert-led panel discussions.
Abstract: Background Globally, an estimated 15·6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the association between injecting drug use (IDU) in young people and rates of injecting and sexual risk behaviours at the country level.
Register now: https://zoom.us/webinar/register/WN_hsaJ4PLoT--qncT2jOmSKQ
This article introduces the emergence of adulterant cutting agents in street drugs in the United States and considers the synergistic effects that is compounding the opioids crisis in the U.S. The article outlines the role of the Colombo Plan in pioneering identification of these substances around the world over the past years with support from the U.S.
Question: Is 800 μg of naloxone hydrochloride administered intranasally as effective in reversing opioid overdose as the same dose administered intramuscularly?
Dependence to prescription and over-the-counter (OTC) drugs represents an increasing public health and clinical problem both in England and internationally. However, relatively little is known about those affected, particularly in relation to their management at drug dependence treatment centres.